Anal Cancer Diagnoses and Deaths Are Rising in the U.S.
A study showing the rates of anal cancer diagnoses and deaths rising in the U.S. underscores the importance of early detection and prevention.
Progress Against Cancer
A study showing the rates of anal cancer diagnoses and deaths rising in the U.S. underscores the importance of early detection and prevention.
People who have been diagnosed with cancer are more likely than those without a cancer history to adhere to measures like wearing masks and avoiding crowded areas, and CAR-T cell therapy is becoming an option for treating more types of cancer.
Proposed changes to lung cancer screening guidelines would double the number of people eligible for yearly CT scans, and more news of the week from Cancer Today.
The COVID-19 pandemic remains at the center of health and science news as cases of the disease continue to rise in the United States and worldwide. In recent days, global cases of COVID-19 exceeded 10 million, and have resulted in nearly 500,000 deaths. Cases in the United States have surpassed all other countries and have topped 2.5 million, with more than 125,000 deaths as a result.
A study finds that incidence of thyroid cancer rose by 169% between 1990 and 2017, and more news of the week from Cancer Today.
Persistent infections with pathogens—such as the human papillomavirus (HPV), hepatitis B and C viruses (HBV/HCV), H. pylori, and others—represent a major risk factor for cancer incidence worldwide. Indeed, an analysis published in Lancet Oncology estimated that 2.2 million cancer cases in 2018 were attributable to infections, representing 13 percent of all global cancer cases (excluding non-melanoma skin cancers). While vaccines exist for many of these pathogens, access to them is not universal.
A study finds that hereditary mutations are elevated in early-onset cancers, and more news of the week from Cancer Today.
Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.
Researchers are investigating why certain patients have an exceptional response to a particular drug.
COVID-19 has had a disproportionate impact on Black and Latino Americans, as well as members of other minority groups.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More